Segal McCambridge Partner, Jeffrey Singer, Has Been Invited to Become a Featured Speaker at Mealey'sTM Defense Strategies in Pharmaceutical Litigation Conference


November 29, 2005

Segal McCambridge partner, Jeffrey Singer, has been invited to become a featured speaker at Mealey'sTM Defense Strategies in Pharmaceutical Litigation Conference, to be held on January 26-27, 2006 at The Ritz-Carlton, Laguna Niguel, Dana Point, CA.

Mr. Singer will take part in two panel discussions. The first panel discussion entitled, "Responding Effectively to an Industry Under Attack," Counsel and participants will provide a detailed overview of the latest themes used to attack pharmaceutical manufacturers through the news and mass media as well as in the courtroom, including plaintiffs' attacks on:

- Research and development
- Clinical testing
- Sales and marketing
- Over-promotion
- Patient safety vs. profits

Counsel and in-house representatives will then address methods for anticipating and responding to these lines of attack and for successfully neutralizing prior adverse verdicts.

The second panel discussion is entitled, "Defusing Punitive Damages at Trial." Topics discussed during this panel will include:

• Preventing juries from returning verdicts with punitive damages
• Creative approaches to defending punitive damages
• Have there been changes made to standardized instructions in the post-Campbell era?

For additional information about this conference, please click here.